_____________________________________________________________________________________ Paxman
Scalp Cooling
Looking ahead, operational excellence is at the top of Paxman’ s agenda, underpinned by five strategic priorities for 2026 and beyond. Richard outlines them:“ The first is commercialization of our new products, and the second relates to reimbursement in the US, which is, ultimately, the primary driver of our growth. Our third priority is overall revenue growth across international markets, which we manage separately from the US business. The fourth and fifth fall under clinical excellence and operational excellence, respectively. Clinical excellence is centered on research and development to continue pushing the science forward, stay ahead of the field and own our position as the leader in scalp cooling. Operational excellence is perhaps the area I feel most strongly about getting right over the next couple of years. As we continue to grow and scale, and we expect to grow significantly over the next five years, it is essential that our internal processes keep pace.
“ Over the past two years, we have invested considerable effort in business process mapping to genuinely understand our process flows and how we can improve them over the longer term for greater efficiencies. Beyond efficiency, it is also about making our people’ s work valuable. For example, I do not want our team spending time on double-processing or manual data entry, as those are exactly the kinds of tasks that AI and automation should be handling,” Richard concludes.
Three decades on, Paxman remains driven by the same purpose that started it, albeit with a strengthened global footprint and more clinical evidence, promising an even more purposeful future ahead. ■
www. paxmanscalpcooling. com
manufacturing-today. com 225